A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS

NCT03365414 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawal of support of product for trial

Conditions

Postural Orthostatic Tachycardia Syndrome

Interventions

BIOLOGICAL: Albumin (Human) 5%, USP
DRUG: Normal Saline 0.9% Infusion Solution Bag

Sponsor

University of Alberta